Iterum Therapeutics Announces Board and Executive Changes
Ticker: ITRM · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1659323
| Field | Detail |
|---|---|
| Company | Iterum Therapeutics PLC (ITRM) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
Related Tickers: ITRM
TL;DR
Iterum Therapeutics shakes up its board and executive pay. Big changes ahead?
AI Summary
Iterum Therapeutics plc announced on March 7, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans.
Why It Matters
Changes in a company's leadership and compensation structures can signal shifts in strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Iterum Therapeutics plc (company) — Registrant
- March 07, 2025 (date) — Date of earliest event reported
- Ireland (location) — State of Incorporation
- 3 Dublin Landings North Wall Quay (address) — Principal Executive Offices
FAQ
Who has departed from Iterum Therapeutics plc's board or officer positions?
The filing indicates the departure of certain officers and directors, though specific names are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 07, 2025.
What is the primary business of Iterum Therapeutics plc?
Iterum Therapeutics plc is in the Pharmaceutical Preparations industry, SIC code 2834.
Where are Iterum Therapeutics plc's principal executive offices located?
The principal executive offices are located at 3 Dublin Landings, North Wall Quay, Dublin 1, Ireland.
What specific items are covered in this 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as other events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Iterum Therapeutics plc (ITRM).